Investors Sell Shares of Johnson & Johnson (JNJ) on Strength (JNJ)

Traders sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Monday. $147.46 million flowed into the stock on the tick-up and $266.11 million flowed out of the stock on the tick-down, for a money net flow of $118.65 million out of the stock. Of all equities tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $0.97 for the day and closed at $145.76

Several equities analysts have recently issued reports on the stock. Piper Jaffray Companies reiterated a “hold” rating and set a $120.00 target price on shares of Johnson & Johnson in a report on Wednesday, October 4th. Vetr lowered shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $129.62 target price for the company. in a report on Friday, October 13th. Stifel Nicolaus lifted their target price on shares of Johnson & Johnson from $140.00 to $142.00 and gave the company a “hold” rating in a report on Wednesday, October 18th. Wells Fargo & Co upgraded shares of Johnson & Johnson from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $140.00 to $149.00 in a report on Monday, October 9th. Finally, JPMorgan Chase & Co. lowered shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $145.94.

The firm has a market capitalization of $394,810.00, a price-to-earnings ratio of 25.51, a price-to-earnings-growth ratio of 2.75 and a beta of 0.80. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $19.65 billion during the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.68 EPS. sell-side analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a yield of 2.29%. Johnson & Johnson’s dividend payout ratio is presently 58.33%.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Lenox Wealth Advisors Inc. raised its stake in Johnson & Johnson by 0.6% during the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the last quarter. Landmark Financial Advisors LLC grew its position in shares of Johnson & Johnson by 0.4% during the 2nd quarter. Landmark Financial Advisors LLC now owns 1,962 shares of the company’s stock valued at $259,000 after acquiring an additional 7 shares during the period. Paradigm Financial Advisors LLC grew its position in shares of Johnson & Johnson by 0.3% during the 2nd quarter. Paradigm Financial Advisors LLC now owns 2,649 shares of the company’s stock valued at $350,000 after acquiring an additional 9 shares during the period. Premier Asset Management LLC grew its position in shares of Johnson & Johnson by 0.4% during the 2nd quarter. Premier Asset Management LLC now owns 2,749 shares of the company’s stock valued at $363,000 after acquiring an additional 12 shares during the period. Finally, Lbmc Investment Advisors LLC grew its position in shares of Johnson & Johnson by 0.4% during the 2nd quarter. Lbmc Investment Advisors LLC now owns 3,718 shares of the company’s stock valued at $492,000 after acquiring an additional 14 shares during the period. Institutional investors and hedge funds own 65.71% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://sportsperspectives.com/2018/01/17/investors-sell-shares-of-johnson-johnson-jnj-on-strength-jnj-2.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply